Nerve Agents
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
488 Subpart A—Organic Pesticide Chemicals Manufacturing
§ 455.11 40 CFR Ch. I (7–1–12 Edition) chemical products and be considered a this subpart are applicable to dis- ‘‘stand-alone’’ PFPR facility. charges resulting from the manufac- ture of the following organic active in- [43 FR 17776, Apr. 25, 1978, as amended at 50 FR 40701, Oct. 4, 1985; 51 FR 44911, Dec. 15, gredients: Aldrin, BHC, Captan, 1986; 58 FR 50689, Sept. 28, 1993; 61 FR 57548, Chlordane, DDD, DDE, DDT, Dichloran, Nov. 6, 1996] Dieldrin, Endosulfan, Endrin, Hepta- chlor, Lindane, Methoxychlor, Mirex, Subpart A—Organic Pesticide PCNB, Toxaphene, Trifluralin, Chemicals Manufacturing Azinphos Methyl, Demeton-O, Demeton-S, Diazinon, Disulfoton, Mal- Subcategory athion, Parathion Methyl, Parathion Ethyl, Aminocarb, Carbaryl, SOURCE: 43 FR 44846, Sept. 29, 1978, unless Methiocarb, Mexacarbate, Propoxur, otherwise noted. Barban, Chlorpropham, Diuron, Fenuron, Fenuron-TCA, Linuron, § 455.11 Compliance date for pretreatment standards for existing Monuron, Monuron-TCA, Neubron, sources (PSES). Propham, Swep, 2,4-D, Dicamba, Silvex, 2,4,5-T, Siduron, Perthane, and All discharges subject to Dicofol. pretreatment standards for existing (c) The intermediates used to manu- sources (PSES) in subparts A and B of facture the active ingredients and ac- this part must comply with the stand- tive ingredients used solely in experi- ards no later than September 28, 1993. mental pesticides are excluded from [61 FR 57549, Nov. 6, 1996] coverage in this subpart. Insecticidal pathogenic organisms such as Bacillus § 455.20 Applicability; description of thuringiensis, insect growth hormones, the organic pesticide chemicals plant extracts such as pyrethrins; sex manufacturing subcategory. attractants and botanicals such as Ro- (a) For the purpose of calculating and tenone are also excluded from BPT applying effluent limitations for COD, coverage in this subpart. -
Malathion General Fact Sheet
MALATHION GENERAL FACT SHEET What is malathion Malathion is an insecticide in the chemical family known as organophosphates. Products containing malathion are used outdoors to control a wide variety of insects in agricultural settings and around people’s homes. Malathion has also been used in public health mosquito control and fruit fly eradication programs. Malathion may also be found in some special shampoos for treating lice. Malathion was first registered for use in the United States in 1956. What are some products that contain malathion Products containing malathion may be liquids, dusts, wettable powders, or emulsions. There are thousands of products contain- ing malathion registered for use in the United States. Always follow label instructions and take steps to avoid exposure. If any exposures occur, be sure to follow the First Aid instructions on the product label carefully. For additional treatment advice, contact the Poison Control Center at 1-800-222-1222. If you wish to discuss a pesticide problem, please call 1-800-858-7378. How does malathion work Malathion kills insects by preventing their nervous system from working properly. When healthy nerves send signals to each other, a special chemical messenger travels from one nerve to another to continue the message. The nerve signal stops when an enzyme is released into the space between the nerves. Malathion binds to the enzyme and prevents the nerve signal from stopping. This causes the nerves to signal each other without stopping. The constant nerve signals make it so the insects can’t move or breathe normally and they die. People, pets and other animals can be affected the same way as insects if they are exposed to enough malathion. -
Potential Applicability of Assembled Chemical Weapons Assessment Technologies to RCRA Waste Streams and Contaminated Media EPA 542-R-00-004 August 2000
United States Solid Waste and EPA 542-R-00-004 Environmental Protection Emergency Response August 2000 Agency (5102G) www.epa.gov clu-in.org EPA Potential Applicability of Assembled Chemical Weapons Assessment Technologies to RCRA Waste Streams and Contaminated Media EPA 542-R-00-004 August 2000 POTENTIAL APPLICABILITY OF ASSEMBLED CHEMICAL WEAPONS ASSESSMENT TECHNOLOGIES TO RCRA WASTE STREAMS AND CONTAMINATED MEDIA U.S. Environmental Protection Agency Office of Solid Waste and Emergency Response Technology Innovation Office Washington, DC 20460 Potential Applicability of ACWA Technologies to RCRA Waste Streams and Contaminated Media NOTICE AND DISCLAIMER This document was prepared by the U.S. Environmental Protection Agency’s Technology Innovation Office with support under EPA Contract Number 68-W-99-003. It is intended to raise the awareness of the technologies included in the Assembled Chemical Weapons Assessment (ACWA) program, and presents an overview of each technology, including its applicability, performance, and other factors. Information about the technologies was obtained from the technology providers. No testing or evaluation was conducted by EPA during preparation of this document, and an independent assessment of this information was beyond EPA’s scope. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. For more information about this project, please contact: John Kingscott, U.S. Environmental Protection Agency, Technology Innovation Office, Ariel Rios Building, 1200 Pennsylvania Avenue, N.W. (MS 5102G), Washington, D.C., 20460; (703) 603-7189; e-mail: [email protected]. This document may be obtained from EPA’s web site at www.epa.gov/tio, or at clu-in.org. -
For Methyl Parathion
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON D.C., 20460 OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES MEMORANDUM DATE: July 31, 2006 SUBJECT: Finalization of Interim Reregistration Eligibility Decisions (IREDs) and Interim Tolerance Reassessment and Risk Management Decisions (TREDs) for the Organophosphate Pesticides, and Completion of the Tolerance Reassessment and Reregistration Eligibility Process for the Organophosphate Pesticides FROM: Debra Edwards, Director Special Review and Reregistration Division Office of Pesticide Programs TO: Jim Jones, Director Office of Pesticide Programs As you know, EPA has completed its assessment of the cumulative risks from the organophosphate (OP) class of pesticides as required by the Food Quality Protection Act of 1996. In addition, the individual OPs have also been subject to review through the individual- chemical review process. The Agency’s review of individual OPs has resulted in the issuance of Interim Reregistration Eligibility Decisions (IREDs) for 22 OPs, interim Tolerance Reassessment and Risk Management Decisions (TREDs) for 8 OPs, and a Reregistration Eligibility Decision (RED) for one OP, malathion.1 These 31 OPs are listed in Appendix A. EPA has concluded, after completing its assessment of the cumulative risks associated with exposures to all of the OPs, that: (1) the pesticides covered by the IREDs that were pending the results of the OP cumulative assessment (listed in Attachment A) are indeed eligible for reregistration; and 1 Malathion is included in the OP cumulative assessment. However, the Agency has issued a RED for malathion, rather than an IRED, because the decision was signed on the same day as the completion of the OP cumulative assessment. -
AASLD PRACTICE GUIDELINES Diagnosis and Management of Autoimmune Hepatitis
AASLD PRACTICE GUIDELINES Diagnosis and Management of Autoimmune Hepatitis Michael P. Manns,1 Albert J. Czaja,2 James D. Gorham,3 Edward L. Krawitt,4 Giorgina Mieli-Vergani,5 Diego Vergani,6 and John M. Vierling7 This guideline has been approved by the American ment on Guidelines;3 and (4) the experience of the Association for the Study of Liver Diseases (AASLD) authors in the specified topic. and represents the position of the Association. These recommendations, intended for use by physi- cians, suggest preferred approaches to the diagnostic, 1. Preamble therapeutic and preventive aspects of care. They are intended to be flexible, in contrast to standards of Clinical practice guidelines are defined as ‘‘systemati- care, which are inflexible policies to be followed in ev- cally developed statements to assist practitioner and ery case. Specific recommendations are based on rele- patient decisions about appropriate heath care for spe- vant published information. To more fully characterize 1 cific clinical circumstances.’’ These guidelines on the quality of evidence supporting the recommenda- autoimmune hepatitis provide a data-supported tions, the Practice Guidelines Committee of the approach to the diagnosis and management of this dis- AASLD requires a class (reflecting benefit versus risk) ease. They are based on the following: (1) formal and level (assessing strength or certainty) of evidence review and analysis of the recently-published world lit- to be assigned and reported with each recommenda- erature on the topic [Medline search]; (2) American tion.4 The grading system applied to the recommenda- College of Physicians Manual for Assessing Health tions has been adapted from the American College of 2 Practices and Designing Practice Guidelines; (3) Cardiology and the American Heart Association Prac- guideline policies, including the AASLD Policy on the tice Guidelines, and it is given below (Table 1). -
Ust Be Registered by Reregistration EPA, Based on Scientific Studies Showing That They Can Be Used Without Posing Unreasonable Risks to People Or the Environment
United States Prevention, Pesticides EPA-738-F00-009 Environmental Protection And Toxic Substances September 2000 Agency (7508C) R.E.D. FACTS Ethyl Parathion Pesticide All pesticides sold or distributed in the United States must be registered by Reregistration EPA, based on scientific studies showing that they can be used without posing unreasonable risks to people or the environment. Because of advances in scientific knowledge, the law requires that pesticides which were first registered before November 1, 1984, be reregistered to ensure that they meet today's more stringent standards. In evaluating pesticides for reregistration, EPA obtains and reviews a complete set of studies from pesticide producers, describing the human health and environmental effects of each pesticide. To implement provisions of the Food Quality Protection Act (FQPA) of 1996, EPA considers the special sensitivity of infants and children to pesticides, as well as aggregate exposure of the public to pesticide residues from all sources, and the cumulative effects of pesticides and other compounds with common mechanisms of toxicity. The Agency develops any mitigation measures or regulatory controls needed to effectively reduce each pesticide's risks. EPA then reregisters pesticides that meet the safety standard of the FQPA and can be used without posing unreasonable risks to human health or the environment. When a pesticide is eligible for reregistration, EPA explains the basis for its decision in a Reregistration Eligibility Decision (RED) document. This fact sheet serves as and explains the Agency’s Reregistration Eligibility Decision for case 0155, ethyl parathion. Use Profile Ethyl parathion is a restricted use organophosphate insecticide/miticide used to control a broad spectrum of pests on alfalfa, barley, canola, corn, cotton, sorghum, soybeans, sunflowers, and wheat. -
US EPA, Pesticide Product Label, ORTHO MALATHION 50 INSECT
23V 73^ f UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 Jff***^ OFFICE OF WAV 00 Onit CHEMICAL SAFETY AND MAY 4 0 201] POLLUTION PREVENTION James Wallace The Scotts Company d/b/a The Ortho Group P.O.Box 190 Marysville, OH 43040 Subject: Submission of amended labeling per May 2009 Malathion RED Label Table EPA Reg. No. 239-739 Submissions dated March 5, 2010 Dear Mr. Wallace: The proposed labeling referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), is acceptable under FIFRA § 3(c)(5) provided that you submit two copies of your final printed label before you release the product for shipment. Products shipped after 12 months from the date of this amendment or the next printing of the label whichever occurs first, must bear the new revised label. Your release for shipment of the product bearing the amended label constitutes acceptance of these conditions. If these conditions are not complied with, the registration will be subject to cancellation in accordance with FIFRA sec. 6(e). The Basic Confidential Statement of Formula (CSF) dated 2/19/10 is acceptable. All other CSF's including Alternates have been superseded by this new CSF. This has been added to your record. Your product has met and complied with the risk mitigation provisions of the Malathion RED and therefore your product is reregistered pursuant to FIFRA § 4(g)(2)(C). But note, EPA is currently reassessing the cumulative impacts of organophosphates and that review may impact your product once complete. -
Malathion) Lotion, 0.5% Rx Only
NDC 51672-5276-4 Ovide® (malathion) Lotion, 0.5% Rx Only For topical use only. Not for oral or ophthalmic use. DESCRIPTION OVIDE Lotion contains 0.005 g of malathion per mL in a vehicle of isopropyl alcohol (78%), terpineol, dipentene, and pine needle oil. The chemical name of malathion is (±) - [(dimethoxyphosphinothioyl) - thio] butanedioic acid diethyl ester. Malathion has a molecular weight of 330.36, represented by C10H19O6PS2, and has the following chemical structure: CLINICAL PHARMACOLOGY Malathion is an organophosphate agent which acts as a pediculicide by inhibiting cholinesterase activity in vivo. Inadvertent transdermal absorption of malathion has occurred from its agricultural use. In such cases, acute toxicity was manifested by excessive cholinergic activity, i.e., increased sweating, salivary and gastric secretion, gastrointestinal and uterine motility, and bradycardia (see OVERDOSAGE). Because the potential for transdermal absorption of malathion from OVIDE Lotion is not known at this time, strict adherence to the dosing instructions regarding its use in children, method of application, duration of exposure, and frequency of application is required. INDICATIONS AND USAGE OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair. CONTRAINDICATIONS OVIDE Lotion is contraindicated for neonates and infants because their scalps are more permeable and may have increased absorption of malathion. OVIDE Lotion should also not be used on individuals known to be sensitive to malathion or any of the ingredients in the vehicle. WARNINGS 1. OVIDE Lotion is flammable. The lotion and wet hair should not be exposed to open flames or electric heat sources, including hair dryers and electric curlers. -
Verification of Chemical Warfare Agent Exposure in Human Samples
Toxichem Krimtech 2013;80(Special Issue):288 Verification of chemical warfare agent exposure in human samples Paul W. Elsinghorst, Horst Thiermann, Marianne Koller Institut für Pharmakologie und Toxikologie der Bundeswehr, München Abstract Aim: This brief presentation provides an overview of methods that have been developed for the verification of human exposure to chemical warfare agents. Methods: GC–MS detection of nerve agents (V- and G-type) has been carried out with respect to unreacted agents as well as enzyme-bound species and metabolites. Methods involving di- rect SPE from plasma, fluoride-induced release of protein-bound nerve agents in plasma and analysis of their metabolites in plasma and urine have been developed. Exposure to blistering agents, i.e., sulfur mustard, has been verified by GC–MS detection of the unreacted agent in plasma and by LC– and GC–MS analysis of its metabolites in urine. Results: After incorporation nerve agents quickly bind to proteins, e.g., acetylcholinesterase, butyrylcholinesterase or serum albumin, and only small parts remain freely circulating for a few hours (G-type) or up to 2 days (V-type). Concurrently they are converted to O-alkyl methylphosphonic acids by phosphotriesterases and/or simply by aqueous hydrolysis. As a re- sult, different biomarkers can be detected depending on the time passed between exposure and sampling. Unreacted V-type agents can be detected in plasma for 2 days, the O-alkyl methyl- phosphonic acids in plasma for about 2–4 days and in urine for up to 1 week. Fluoride-indu- ced release of protein-bound nerve agents can be carried out until 3 weeks post exposure. -
Nerve Agent - Lntellipedia Page 1 Of9 Doc ID : 6637155 (U) Nerve Agent
This document is made available through the declassification efforts and research of John Greenewald, Jr., creator of: The Black Vault The Black Vault is the largest online Freedom of Information Act (FOIA) document clearinghouse in the world. The research efforts here are responsible for the declassification of MILLIONS of pages released by the U.S. Government & Military. Discover the Truth at: http://www.theblackvault.com Nerve Agent - lntellipedia Page 1 of9 Doc ID : 6637155 (U) Nerve Agent UNCLASSIFIED From lntellipedia Nerve Agents (also known as nerve gases, though these chemicals are liquid at room temperature) are a class of phosphorus-containing organic chemicals (organophosphates) that disrupt the mechanism by which nerves transfer messages to organs. The disruption is caused by blocking acetylcholinesterase, an enzyme that normally relaxes the activity of acetylcholine, a neurotransmitter. ...--------- --- -·---- - --- -·-- --- --- Contents • 1 Overview • 2 Biological Effects • 2.1 Mechanism of Action • 2.2 Antidotes • 3 Classes • 3.1 G-Series • 3.2 V-Series • 3.3 Novichok Agents • 3.4 Insecticides • 4 History • 4.1 The Discovery ofNerve Agents • 4.2 The Nazi Mass Production ofTabun • 4.3 Nerve Agents in Nazi Germany • 4.4 The Secret Gets Out • 4.5 Since World War II • 4.6 Ocean Disposal of Chemical Weapons • 5 Popular Culture • 6 References and External Links --------------- ----·-- - Overview As chemical weapons, they are classified as weapons of mass destruction by the United Nations according to UN Resolution 687, and their production and stockpiling was outlawed by the Chemical Weapons Convention of 1993; the Chemical Weapons Convention officially took effect on April 291997. Poisoning by a nerve agent leads to contraction of pupils, profuse salivation, convulsions, involuntary urination and defecation, and eventual death by asphyxiation as control is lost over respiratory muscles. -
Warning: the Following Lecture Contains Graphic Images
What the новичок (Novichok)? Why Chemical Warfare Agents Are More Relevant Than Ever Matt Sztajnkrycer, MD PHD Professor of Emergency Medicine, Mayo Clinic Medical Toxicologist, Minnesota Poison Control System Medical Director, RFD Chemical Assessment Team @NoobieMatt #ITLS2018 Disclosures In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards, the American Nurses Credentialing Center’s Commission (ANCC) and the Commission on Accreditation for Pre-Hospital Continuing Education (CAPCE), states presenters must disclose the existence of significant financial interests in or relationships with manufacturers or commercial products that may have a direct interest in the subject matter of the presentation, and relationships with the commercial supporter of this CME activity. The presenter does not consider that it will influence their presentation. Dr. Sztajnkrycer does not have a significant financial relationship to report. Dr. Sztajnkrycer is on the Editorial Board of International Trauma Life Support. Specific CW Agents Classes of Chemical Agents: The Big 5 The “A” List Pulmonary Agents Phosgene Oxime, Chlorine Vesicants Mustard, Phosgene Blood Agents CN Nerve Agents G, V, Novel, T Incapacitating Agents Thinking Outside the Box - An Abbreviated List Ammonia Fluorine Chlorine Acrylonitrile Hydrogen Sulfide Phosphine Methyl Isocyanate Dibotane Hydrogen Selenide Allyl Alcohol Sulfur Dioxide TDI Acrolein Nitric Acid Arsine Hydrazine Compound 1080/1081 Nitrogen Dioxide Tetramine (TETS) Ethylene Oxide Chlorine Leaks Phosphine Chlorine Common Toxic Industrial Chemical (“TIC”). Why use it in war/terror? Chlorine Density of 3.21 g/L. Heavier than air (1.28 g/L) sinks. Concentrates in low-lying areas. Like basements and underground bunkers. Reacts with water: Hypochlorous acid (HClO) Hydrochloric acid (HCl). -
Chlorpyrifos (Dursban) Ddvp (Dichlorvos) Diazinon Malathion Parathion
CHLORPYRIFOS (DURSBAN) DDVP (DICHLORVOS) DIAZINON MALATHION PARATHION Method no.: 62 Matrix: Air Procedure: Samples are collected by drawing known volumes of air through specially constructed glass sampling tubes, each containing a glass fiber filter and two sections of XAD-2 adsorbent. Samples are desorbed with toluene and analyzed by GC using a flame photometric detector (FPD). Recommended air volume and sampling rate: 480 L at 1.0 L/min except for Malathion 60 L at 1.0 L/min for Malathion Target concentrations: 1.0 mg/m3 (0.111 ppm) for Dichlorvos (PEL) 0.1 mg/m3 (0.008 ppm) for Diazinon (TLV) 0.2 mg/m3 (0.014 ppm) for Chlorpyrifos (TLV) 15.0 mg/m3 (1.11 ppm) for Malathion (PEL) 0.1 mg/m3 (0.008 ppm) for Parathion (PEL) Reliable quantitation limits: 0.0019 mg/m3 (0.21 ppb) for Dichlorvos (based on the RAV) 0.0030 mg/m3 (0.24 ppb) for Diazinon 0.0033 mg/m3 (0.23 ppb) for Chlorpyrifos 0.0303 mg/m3 (2.2 ppb) for Malathion 0.0031 mg/m3 (0.26 ppb) for Parathion Standard errors of estimate at the target concentration: 5.3% for Dichlorvos (Section 4.6.) 5.3% for Diazinon 5.3% for Chlorpyrifos 5.6% for Malathion 5.3% for Parathion Status of method: Evaluated method. This method has been subjected to the established evaluation procedures of the Organic Methods Evaluation Branch. Date: October 1986 Chemist: Donald Burright Organic Methods Evaluation Branch OSHA Analytical Laboratory Salt Lake City, Utah 1 of 27 T-62-FV-01-8610-M 1.